Literature DB >> 10330160

Expression of the p56(Lck) Y505F mutation in CD45-deficient mice rescues thymocyte development.

J R Seavitt1, L S White, K M Murphy, D Y Loh, R M Perlmutter, M L Thomas.   

Abstract

Mice deficient in the transmembrane protein tyrosine phosphatase CD45 exhibit a block in thymocyte development. To determine whether the block in thymocyte development was due to the inability to dephosphorylate the inhibitory phosphorylation site (Y505) in p56(lck) (Lck), we generated CD45-deficient mice that express transgenes for the Lck Y505F mutation and the DO11.10 T-cell antigen receptor (TCR). CD4 single-positive T cells developed and accumulated in the periphery. Treatment with antigen resulted in thymocyte apoptosis and the loss of transgenic-TCR-bearing cells. Peripheral CD45-deficient T cells from the mice expressing both transgenes responded to antigen by increasing CD69 expression, interleukin-2 production, and proliferation. These results indicate that thymocyte development requires the dephosphorylation of the inhibitory site in Lck by CD45.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330160      PMCID: PMC104379          DOI: 10.1128/MCB.19.6.4200

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  Positive and negative selection of T lymphocytes.

Authors:  D Y Loh; W C Sha; C A Nelson; R D Newberry; D M Kranz; J H Russell
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1989

2.  Activation of p56lck through mutation of a regulatory carboxy-terminal tyrosine residue requires intact sites of autophosphorylation and myristylation.

Authors:  N Abraham; A Veillette
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

3.  Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines.

Authors:  H L Ostergaard; D A Shackelford; T R Hurley; P Johnson; R Hyman; B M Sefton; I S Trowbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo.

Authors:  K M Murphy; A B Heimberger; D Y Loh
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

5.  Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway.

Authors:  G A Koretzky; J Picus; M L Thomas; A Weiss
Journal:  Nature       Date:  1990-07-05       Impact factor: 49.962

6.  Rapid activation of the T-cell tyrosine protein kinase pp56lck by the CD45 phosphotyrosine phosphatase.

Authors:  T Mustelin; K M Coggeshall; A Altman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

7.  Coclustering CD45 with CD4 or CD8 alters the phosphorylation and kinase activity of p56lck.

Authors:  H L Ostergaard; I S Trowbridge
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

8.  Mutation of a site of tyrosine phosphorylation in the lymphocyte-specific tyrosine protein kinase, p56lck, reveals its oncogenic potential in fibroblasts.

Authors:  K E Amrein; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

9.  Regulation of pp56lck during T-cell activation: functional implications for the src-like protein tyrosine kinases.

Authors:  J D Marth; D B Lewis; C B Wilson; M E Gearn; E G Krebs; R M Perlmutter
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

10.  Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation.

Authors:  J T Pingel; M L Thomas
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

View more
  18 in total

1.  A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras.

Authors:  K W Lynch; A Weiss
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 2.  Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases.

Authors:  Michelle L Hermiston; Zheng Xu; Ravindra Majeti; Arthur Weiss
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

3.  Development of T-leukaemias in CD45 tyrosine phosphatase-deficient mutant lck mice.

Authors:  M Baker; J Gamble; R Tooze; D Higgins; F T Yang; P C O'Brien; N Coleman; S Pingel; M Turner; D R Alexander
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

4.  EMBO WORKSHOP REPORT: lymphocyte antigen receptor and coreceptor signaling Siena, Italy, November 6-10, 1999.

Authors:  C T Baldari; J L Telford; O Acuto
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

5.  Herpes simplex virus requires VP11/12 to activate Src family kinase-phosphoinositide 3-kinase-Akt signaling.

Authors:  Melany J Wagner; James R Smiley
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

Review 6.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

7.  Binding of the cytoplasmic domain of CD28 to the plasma membrane inhibits Lck recruitment and signaling.

Authors:  Jessica Dobbins; Etienne Gagnon; Jernej Godec; Jason Pyrdol; Dario A A Vignali; Arlene H Sharpe; Kai W Wucherpfennig
Journal:  Sci Signal       Date:  2016-07-26       Impact factor: 8.192

8.  Novel tools to dissect the dynamic regulation of TCR signaling by the kinase Csk and the phosphatase CD45.

Authors:  Ying Xim Tan; Julie Zikherman; Arthur Weiss
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2013-10-07

9.  Selective regulation of TCR signaling pathways by the CD45 protein tyrosine phosphatase during thymocyte development.

Authors:  Rustom Falahati; David Leitenberg
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

Review 10.  Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity.

Authors:  Stephanie M Stanford; Novella Rapini; Nunzio Bottini
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.